These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 5677210)

  • 1. Circadian variation of glucose, insulin, and free fatty acids during long-term use of oral hypoglycaemic agents in diabetes mellitus.
    Rigas AN; Bittles AH; Hadden DR; Montgomery DA
    Br Med J; 1968 Oct; 4(5622):25-8. PubMed ID: 5677210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H; Denes A; Girard J; Collard F; Berger W
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract]   [Full Text] [Related]  

  • 3. [Free fatty acid and triglyceride content of the blood in newly-detected diabetes mellitus with prolonged preservation of normoglycemia as a result of diet therapy in combination with sulfanilamide antidiabetic preparations].
    Bogatyreva ShI; Dzeranova NIa; Zaripova ZKh
    Probl Endokrinol (Mosk); 1973; 19(1):3-7. PubMed ID: 4698453
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of the obese diabetic. A comparative study of placebo, sulfonylurea and phenformin.
    Abramson E; Arky RA
    Metabolism; 1967 Mar; 16(3):204-12. PubMed ID: 5336062
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of short-term metformin treatment on insulin sensitivity of blood glucose and free fatty acids.
    Iannello S; Camuto M; Cavaleri A; Milazzo P; Pisano MG; Bellomia D; Belfiore F
    Diabetes Obes Metab; 2004 Jan; 6(1):8-15. PubMed ID: 14686957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal change of plasma insulin in diabetics with sulfonylurea treatment.
    Toyota T
    Tohoku J Exp Med; 1969 Aug; 98(4):345-56. PubMed ID: 5346206
    [No Abstract]   [Full Text] [Related]  

  • 7. The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.
    Chu PC; Conway MJ; Krouse HA; Goodner CJ
    Ann Intern Med; 1968 Apr; 68(4):757-69. PubMed ID: 4868334
    [No Abstract]   [Full Text] [Related]  

  • 8. Diurnal variations of serum insulin, total glucagon, cortisol, glucose and free fatty acids in normal and diabetic subjects before and after treatment with chlorpropamide.
    Loreti L; Sugase T; Foà PP
    Horm Res; 1974; 5(5):278-92. PubMed ID: 4851417
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of sulfonylureas on lipid levels in diabetic patients].
    Sgambato S; Cristiano L; Torella R
    Rass Int Clin Ter; 1968 Apr; 48(8):455-62. PubMed ID: 5736035
    [No Abstract]   [Full Text] [Related]  

  • 10. The stimulatory effect on insulin secretion in long-term tolbutamide treatment. Immunological determinations of urinary- and serum insulin.
    Johansen K; Orskov H
    Acta Endocrinol (Copenh); 1972 Dec; 71(4):709-15. PubMed ID: 4678208
    [No Abstract]   [Full Text] [Related]  

  • 11. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
    Marble A
    Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes.
    Gougeon R; Styhler K; Morais JA; Jones PJ; Marliss EB
    Diabetes Care; 2000 Jan; 23(1):1-8. PubMed ID: 10857959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attempts to delay the progression of chemical diabetes.
    Jimenez JA; Oppermann W; De Lellis RH; Camerini-Dávalos RA
    Adv Metab Disord; 1970; 1():Suppl 1:421+. PubMed ID: 5446909
    [No Abstract]   [Full Text] [Related]  

  • 16. [The response of serum glucose, free fatty acid and immunoreactive insulin to oral glucose and intravenous tolbutamide in normal, potentially diabetic and diabetic subjects].
    Bigelow-Sherman JD; Shima K; Borden EK; Foà PP; Penhallegon R
    Acta Diabetol Lat; 1970; 7(1):68-92. PubMed ID: 5493440
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of long-term therapy with oral hypoglycemic agents on the oral glucose tolerance test dynamics in male chemical diabetics.
    Tan MH; Graham CA; Bradley RF; Gleason RE; Soeldner JS
    Diabetes; 1977 Jun; 26(6):561-70. PubMed ID: 324835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison between the action of chlorpropamide and an association of chlorpropamide with metformin on the daily fluctuations of glucose and insulin in diabetics].
    Berger W; Goschke H; Denes A
    J Med Lyon; 1972 Feb; 53(222):168 passim. PubMed ID: 5046641
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 20. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.